We are live on ! Find out more
USNA icon

Usana Health Sciences
USNA

Fund managers haven’t disclosed any holdings of USNA yet.

USNA Hedge Fund Activity: Q1 2026 in Review

139 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2026, worth a combined $180M — down 13% from $206M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new USNA positions and 10 closed out — a net gain of 19 holders — while 40 added to existing stakes and 51 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $4.77M. The largest seller was Millennium Management, cutting an estimated $3.82M.

  • 139 institutional investors held Usana Health Sciences (USNA) as of Q1 2026, up from 121 in Q4 2025.
  • Funds reported $180M of Usana Health Sciences stock for Q1 2026, down 13% quarter-over-quarter.
  • 29 funds opened new Usana Health Sciences positions in Q1 2026 and 10 closed out, a net change of +19 holders.
  • The largest Usana Health Sciences buyer in Q1 2026 was AQR Capital Management, an estimated $4.77M added.
  • The largest Usana Health Sciences seller in Q1 2026 was Millennium Management, an estimated $3.82M sold.

Based on aggregated 13F filings for Q1 2026.